国产亚洲AV综合人人澡小说_国产精品免费午夜在线a_国产成人免费观看视频_国产精品国产午夜免费看福利_一区二区三区日韩_撕开丝袜直顶而入在线视频_波多结依无码观看_无遮挡一级毛片私人影院_欧美日韩在线视频专区_国产一级九九久久毛片精品
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.09.01
2017年第三次臨時(shí)股東大會(huì)決議公告
2017.09.01
2017年第三次臨時(shí)股東大會(huì)的法律意見(jiàn)書(shū)
2017.08.30
關(guān)于籌劃發(fā)行股份購(gòu)買(mǎi)資產(chǎn)的停牌進(jìn)展公告
2017.08.25
關(guān)于籌劃發(fā)行股份購(gòu)買(mǎi)資產(chǎn)的停牌進(jìn)展公告
2017.08.25
中天國(guó)富證券有限公司關(guān)于公司重組停牌期間重組進(jìn)展信息披露真實(shí)性、繼續(xù)停牌合理性和6...
2017.08.23
關(guān)于籌劃發(fā)行股份購(gòu)買(mǎi)資產(chǎn)的停牌進(jìn)展公告
2017.08.19
關(guān)于增加2017年度日常經(jīng)營(yíng)性關(guān)聯(lián)交易預(yù)計(jì)金額的公告
2017.08.19
第四屆董事會(huì)第五次會(huì)議決議公告
2017.08.19
2017年半年度財(cái)務(wù)報(bào)告
2017.08.19
關(guān)于全資子公司對(duì)外投資的完成公告
第一頁(yè)
上一頁(yè)
71
72
73
74
75
下一頁(yè)
最后一頁(yè)
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.